PLoS ONE (Jan 2018)

Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus.

  • Mónica Vázquez-Del Mercado,
  • Felipe de J Perez-Vazquez,
  • Eduardo Gomez-Bañuelos,
  • Efrain Chavarria-Avila,
  • Arcelia Llamas-García,
  • Karla I Arrona-Rios,
  • Gustavo Ignacio Diaz-Rubio,
  • Sergio Durán-Barragán,
  • Rosa E Navarro-Hernández,
  • Bethel P Jordán-Estrada,
  • Natalia Prado-Bachega,
  • Miguel A A Gonzalez-Beltran,
  • Carlos Ramos-Becerra,
  • Fernando Grover-Paez,
  • David Cardona-Müller,
  • Ernesto G Cardona-Muñoz

DOI
https://doi.org/10.1371/journal.pone.0207520
Journal volume & issue
Vol. 13, no. 12
p. e0207520

Abstract

Read online

It is well known that cardiovascular diseases (CVD) are a major contributor of death in systemic lupus erythematosus (SLE) as well in other rheumatic illness. In the last decades, there has been a growing development of different methodologies with the purpose of early detection of CVD.ObjectiveThe aim of this study is to correlate the usefulness of subclinical parameters of vascular aging and QRISK 3-2017 score for early detection of CVD in SLE.MethodsClinical assessment including systemic lupus erythematosus disease activity index (SLEDAI) and systemic lupus international collaborating clinics / american college of rheumatology damage index (SLICC/ACR DI), laboratory measurements, carotid ultrasound examination, carotid intima media thickness (cIMT) measurement, carotid distention and diameter analysis, arterial stiffness measurement measured by tonometry and QRISK 3-2017 were done. All results were analyzed by SPSS 24 software.ResultsWe observed correlation between QRISK3 and mean cIMT (rs = 0.534, P ConclusionsWe encourage to the rheumatology community to assess cardiovascular risk in SLE patients with QRISK 3-2017 risk calculator as an alternative method at the outpatient clinic along a complete cardiovascular evaluation when appropriate.